Pilot Randomized Study of RD-X19 Tx Device in Subjects With PCC (Long Covid) in the Outpatient Setting
Not Applicable
Terminated
- Conditions
- Post COVID-19 Condition (PCC)
- Interventions
- Device: RDX-19
- First Posted Date
- 2023-11-02
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- EmitBio Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT06113679
- Locations
- πΊπΈ
Site 2_WellNow Urgent Care and Research, E. Amherst, New York, United States
πΊπΈSite 1_Helios - Physician Quality Care, Milan, Tennessee, United States
Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19
Not Applicable
Completed
- Conditions
- COVID-19
- Interventions
- Device: ShamDevice: RD-X19
- First Posted Date
- 2023-04-18
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- EmitBio Inc.
- Target Recruit Count
- 330
- Registration Number
- NCT05817045
- Locations
- πΊπΈ
305 - Indago Research and Health Center, Hialeah, Florida, United States
πΊπΈ321 - Helios Clinical Research - Kissimmee, Kissimmee, Florida, United States
πΊπΈ338 - Carolina Internal Medicine Associates, Asheville, North Carolina, United States
Evaluation of the RD-X19 Treatment Device in Individuals With Mild to Moderate COVID-19
Not Applicable
Completed
- Conditions
- COVID19
- Interventions
- Device: RD-X19Device: Sham
- First Posted Date
- 2021-07-19
- Last Posted Date
- 2022-04-15
- Lead Sponsor
- EmitBio Inc.
- Target Recruit Count
- 216
- Registration Number
- NCT04966013
- Locations
- πΊπΈ
Site 2 - Innovative Research of West Florida, Inc., Clearwater, Florida, United States
πΊπΈSite 1 - APF Research LLC, Miami, Florida, United States
πΊπΈSite 8 - WellNow Urgent Care, Kalamazoo, Michigan, United States
Phase I/II Safety, Dose Finding & Antiviral Activity of RD-X19 in Mild/Moderate Outpatient COVID-19
Not Applicable
Completed
- Conditions
- COVID19
- Interventions
- Device: RD-X19
- First Posted Date
- 2020-12-10
- Last Posted Date
- 2022-09-08
- Lead Sponsor
- EmitBio Inc.
- Target Recruit Count
- 31
- Registration Number
- NCT04662671
- Locations
- πΊπΈ
Site 2, Miami, Florida, United States
πΊπΈSite 1, College Station, Texas, United States
Acute Safety and Acceptability Study of Experimental Device RD19 for Protection From Human Respiratory Disease Pathogens
Not Applicable
Completed
- Conditions
- Respiratory Tract Infections
- Interventions
- Device: RD19
- First Posted Date
- 2020-09-22
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- EmitBio Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT04557826
- Locations
- πΊπΈ
Carolina Phase I, Raleigh, North Carolina, United States
Β© Copyright 2025. All Rights Reserved by MedPath